Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Regulation and evolving science: neurobehavioral toxicology.

N S Buckholtz, S Panem

    Neurobehavioral Toxicology and Teratology
    |January 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Estrogen replacement therapy for the potential treatment or prevention of Alzheimer's disease.

    Annals of the New York Academy of Sciences·2002
    Same author

    Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society.

    JAMA·1997
    Same author

    Fisher symposium: strategies for the prevention of Alzheimer disease--overview of research planning meeting III.

    Alzheimer disease and associated disorders·1996
    Same author

    The entrepreneurial twist.

    Science (New York, N.Y.)·1994
    Same author

    Alzheimer's disease drug development and testing at the National Institute on Aging.

    Psychopharmacology bulletin·1994
    Same author

    National Institute on Aging collaborative studies in the standardization of cognitive measures.

    Alzheimer disease and associated disorders·1994
    Same journal

    Effects of single exposure to toluene on shock avoidance and time estimation in rats.

    Neurobehavioral toxicology and teratology·1986
    Same journal

    Attention, distraction and reaction time at age 7 years and prenatal alcohol exposure.

    Neurobehavioral toxicology and teratology·1986
    Same journal

    Behavioral effects of chronic manganese administration in rats: locomotor activity studies.

    Neurobehavioral toxicology and teratology·1986
    Same journal

    Duration and intensity of behavioral change after sublethal exposure to soman in rats.

    Neurobehavioral toxicology and teratology·1986
    Same journal

    Acute sulfolane exposure produces temperature-independent and dependent changes in visual evoked potentials.

    Neurobehavioral toxicology and teratology·1986
    Same journal

    Behavioral, neurochemical and physiological effects of repeated exposures to subsymptomatic levels of the anticholinesterase, soman.

    Neurobehavioral toxicology and teratology·1986
    See all related articles

    Introducing neurobehavioral toxicology into regulatory policy requires careful consideration of testing strategies and scientific validity. This case study examines the policy and scientific issues for evaluating emerging toxicological endpoints.

    Area of Science:

    • Environmental toxicology
    • Neurobehavioral toxicology
    • Regulatory science

    Background:

    • Governmental regulatory agencies face challenges integrating novel scientific disciplines.
    • The Environmental Protection Agency (EPA) requires toxicological testing for pesticides and other compounds.
    • Existing toxicological endpoints may not fully capture all potential health and safety risks.

    Purpose of the Study:

    • To explore policy and scientific issues surrounding the incorporation of emerging toxicological endpoints.
    • To use neurobehavioral toxicology as a case study for introducing new biological endpoints into regulatory evaluation.
    • To address the rationale for expanding toxicity testing, current regulatory status, alternative incorporation methods, and consequences of new endpoint requirements.

    Main Methods:

    Related Experiment Videos

    • Policy analysis of regulatory processes for incorporating new scientific data.
    • Case study approach focusing on neurobehavioral toxicology within the EPA's framework.
    • Discussion of scientific considerations for selecting and validating test systems, including test selection, strategy, and assessment of validity, reliability, and sensitivity.

    Main Results:

    • Expansion of toxicity testing endpoints is debated, with neurobehavioral toxicology serving as a key example.
    • Various policy and scientific challenges exist in integrating new toxicological assessments.
    • The selection, strategy, and validation of scientific tests are critical for regulatory acceptance.

    Conclusions:

    • Integrating new scientific endpoints like neurobehavioral toxicology into regulatory frameworks is complex.
    • Careful consideration of policy implications, scientific validity, and testing strategies is essential for effective risk assessment.
    • The process requires a thorough evaluation of the benefits and challenges associated with expanding toxicological testing.